No Data
No Data
Tudor Investment Corp Et Al Makes New $169,000 Investment in Metacrine, Inc. (NASDAQ:MTCR)
Tudor Investment Corp Et Al bought a new stake in Metacrine, Inc. (NASDAQ:MTCR – Get Rating) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commissi
Nasdaq to Delist Shares of Waitr and Calithera Biosciences, Among Others
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersHTG Molecular Diagnostics (NASDAQ:HTGM) shares moved upwards by 33.0% to $6.01 during Wednesday's after-market session. This security traded at a volume of 323.6K shares come close, making up 2
Insider Selling: Metacrine, Inc. (NASDAQ:MTCR) CEO Sells $156,048.05 in Stock
Metacrine, Inc. (NASDAQ:MTCR – Get Rating) CEO Preston Klassen sold 380,605 shares of the company's stock in a transaction that occurred on Thursday, January 26th. The stock was sold at an average pr
Preston Klassen Sells 380,605 Shares of Metacrine, Inc. (NASDAQ:MTCR) Stock
Metacrine, Inc. (NASDAQ:MTCR – Get Rating) CEO Preston Klassen sold 380,605 shares of the firm's stock in a transaction on Thursday, January 26th. The stock was sold at an average price of $0.41, for
Insider Selling: Metacrine, Inc. (NASDAQ:MTCR) Insider Sells 107,054 Shares of Stock
Metacrine, Inc. (NASDAQ:MTCR – Get Rating) insider Michael York sold 107,054 shares of Metacrine stock in a transaction on Thursday, January 26th. The stock was sold at an average price of $0.41, for
No Data
Mang1281 : 这是老千股,快跑